Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02437396 · ClinicalTrials.gov registry record
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
A clinical trial of Inflammation and Oxidative Stress, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT02437396: Recruiting study of Inflammation and Oxidative Stress, sponsored by University of Minnesota.
NCT02437396 is a study of Inflammation and Oxidative Stress that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 34 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02437396, a study of Inflammation and Oxidative Stress, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate oxidative stress and/or inflammation in patients with Gaucher disease type I using a series of biomarkers and correlate with measurements of currently used diagnostic biomarkers.
Primary Outcome
Outcome will be reported as the change in plasma concentration of C5a (ng/ml) from baseline to 6 months in participants with Gaucher disease type 1
Conditions Studied
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-10 |
| Est. Completion | 2026-06-28 |
What NCT02437396 shows while recruiting
NCT02437396 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 0 interventions.
NCT02437396 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02437396 about?
NCT02437396 is a clinical study titled "Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease". The objective of this study is to evaluate oxidative stress and/or inflammation in patients with Gaucher disease type I using a series of biomarkers and correlate with measurements of currently used diagnostic biomarkers.
What is the current status of trial NCT02437396?
This trial is currently recruiting. The enrollment target is 34 participants. The study started on 2015-10. Estimated completion is 2026-06-28.
What conditions does trial NCT02437396 study?
This clinical trial studies the following conditions: Inflammation, Oxidative Stress, Gaucher Disease Type I.
Who is sponsoring clinical trial NCT02437396?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02437396 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02437396's enrollment target sits among peer trials
34 95th of 132 higher than 38 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia